Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Tetsuya, Ichijo"'
Autor:
Tetsuya Ichijo, Hiroyuki Kobayashi, Tomoo Yamazaki, Takeji Umemura, Yuki Yamashita, Shun-Ichi Wakabayashi, Satoru Joshita, Fumihiro Kawakami, Hideyuki Nakazawa, Ayumi Sugiura
Publikováno v:
Journal of Infection and Chemotherapy. 27:1750-1755
Hepatitis C virus (HCV) exacerbation is relatively rare as compared with hepatitis B virus reactivation in patients treated with immunosuppressive or anticancer drugs. We herein present the first reported case of acute exacerbation of chronic hepatit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a75749eca6c2ff7669907d57659e2b8
https://doi.org/10.1016/j.jiac.2021.07.018
https://doi.org/10.1016/j.jiac.2021.07.018
Autor:
Ayumi Sugiura, Satoru Joshita, Yuki Yamashita, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Shuichi Wada, Hiromitsu Mori, Soichiro Shibata, Kaname Yoshizawa, Susumu Morita, Kiyoshi Furuta, Atsushi Kamijo, Akihiro Iijima, Satoko Kako, Atsushi Maruyama, Masakazu Kobayashi, Michiharu Komatsu, Makiko Matsumura, Chiharu Miyabayashi, Tetsuya Ichijo, Aki Takeuchi, Yuriko Koike, Yukio Gibo, Toshihisa Tsukadaira, Hiroyuki Inada, Yoshiyuki Nakano, Seiichi Usuda, Kendo Kiyosawa, Eiji Tanaka, Takeji Umemura
Publikováno v:
Biomedicines, Vol 8, Iss 4, p 74 (2020)
Glecaprevir/pibrentasvir (G/P) are direct-acting antivirals (DAAs) that achieve a high sustained virological response (SVR) rate for hepatitis C virus (HCV) infection. We investigated G/P effectiveness for HCV patients based on real-world experience
Externí odkaz:
https://doaj.org/article/97d75c1ccf174e11b6e6ee93efa333fc
Autor:
Masakazu Kobayashi, Susumu Morita, Kaname Yoshizawa, Tetsuya Ichijo, Makiko Matsumura, Satoru Joshita, Akihiro Matsumoto, Hiroyuki Inada, Chiharu Miyabayashi, Atsushi Kamijo, Ayumi Sugiura, Akihiro Iijima, Yuriko Koike, Hiromitsu Mori, Soichiro Shibata, Kiyoshi Furuta, Satoko Kako, Yukio Gibo, Naoyuki Fujimori, Shuichi Wada, Aki Takeuchi, Eiji Tanaka, Tomoo Yamazaki, Takefumi Kimura, Toshihisa Tsukadaira, Koji Igarashi, Yoko Usami, Michiharu Komatsu, Takeji Umemura, Kendo Kiyosawa, Atsushi Maruyama
Publikováno v:
Journal of Viral Hepatitis. 25:1462-1471
Direct-acting antiviral (DAA) treatment can achieve a high sustained virological response (SVR) rate in patients with hepatitis C virus (HCV) infection regardless of a history of hepatocellular carcinoma (HCC [+]). We examined 838 patients (370 men,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335a49b327a372385313305f730dbbe6
https://doi.org/10.1111/jvh.12973
https://doi.org/10.1111/jvh.12973
Autor:
Satoru Joshita, Chiharu Miyabayashi, Masakazu Kobayashi, Seiichi Usuda, Soichiro Shibata, Kendo Kiyosawa, Atsushi Maruyama, Yuki Yamashita, Kiyoshi Furuta, Hiroyuki Inada, Satoko Kako, Naoyuki Fujimori, Yukio Gibo, Ayumi Sugiura, Shuichi Wada, Yuriko Koike, Toshihisa Tsukadaira, Eiji Tanaka, Susumu Morita, Kaname Yoshizawa, Tetsuya Ichijo, Michiharu Komatsu, Takeji Umemura, Makiko Matsumura, Aki Takeuchi, Akihiro Matsumoto, Atsushi Kamijo, Akihiro Iijima, Hiromitsu Mori, Tomoo Yamazaki, Takefumi Kimura, Yoshiyuki Nakano
Publikováno v:
Biomedicines
Volume 8
Issue 4
Biomedicines, Vol 8, Iss 74, p 74 (2020)
Volume 8
Issue 4
Biomedicines, Vol 8, Iss 74, p 74 (2020)
Glecaprevir/pibrentasvir (G/P) are direct-acting antivirals (DAAs) that achieve a high sustained virological response (SVR) rate for hepatitis C virus (HCV) infection. We investigated G/P effectiveness for HCV patients based on real-world experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f649f86bd3b0e9bf3128c897c5e589
https://doi.org/10.3390/biomedicines8040074
https://doi.org/10.3390/biomedicines8040074
Laparoscopic findings of congenital hepatic fibrosis: A case report and review of the published work
Autor:
Satoru Joshita, Eiji Tanaka, Tadanobu Nagaya, Naoki Tanaka, Yuki Ichikawa, So-Ichirou Shibata, Akihiro Matsumoto, Tetsuya Ichijo, Michiharu Komatsu, Takeji Umemura, Takefumi Kimura, Susumu Morita, Kaname Yoshizawa
Publikováno v:
Hepatology Research. 44:818-824
A 33-year-old man visited a hospital after vomiting blood. Emergent esophagogastroduodenoscopy revealed the presence of varices in the lower esophagus. The patient did not have a past history of alcohol consumption and was negative for hepatitis B an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bad17e9c39b9d218a6f65cfb3a70aeee
https://doi.org/10.1111/hepr.12178
https://doi.org/10.1111/hepr.12178
Autor:
Akihiro Matsumoto, Eiji Tanaka, Satoru Joshita, Kendo Kiyosawa, Morikazu Onji, Naoki Tanaka, Yoshihiko Katsuyama, Michiharu Komatsu, Kaname Yoshizawa, Masao Ota, Takeji Umemura, Tetsuya Ichijo, Masanori Abe
Publikováno v:
Hepatology. 56:668-676
The long-term outcome of patients with autoimmune hepatitis (AIH) in Japan has not been well-defined. The aim of this study was to clarify the outcome of this disease over a long follow-up period compared with that of the general Japanese population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691066e96914123dc6ca2ece3caee09e
https://doi.org/10.1002/hep.25658
https://doi.org/10.1002/hep.25658
Autor:
Takeji, Umemura, Satoru, Joshita, Tetsuya, Ichijo, Kaname, Yoshizawa, Yoshihiko, Katsuyama, Eiji, Tanaka, Masao, Ota, Nobuyoshi, Yamamura
Publikováno v:
HEPATOLOGY. 55(2):506-511
Along with twin and family studies, recent genome-wide association studies suggest that genetic factors contribute to the susceptibility and severity of primary biliary cirrhosis (PBC). Although several reports have demonstrated that the human leukoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa0fcc29aa66d27a664d66c0813e930a
https://soar-ir.repo.nii.ac.jp/records/19060
https://soar-ir.repo.nii.ac.jp/records/19060
Autor:
Yoshihiko Katsuyama, Tetsuya Ichijo, Satoru Joshita, Masao Ota, Takeji Umemura, Suguru Yoneda, Akihiro Matsumoto, Kaname Yoshizawa, Eiji Tanaka
Publikováno v:
Antiviral Therapy. 16:1073-1080
Background Both IL28B gene polymorphisms and serum levels of interleukin (IL)-10, IL-12p40 and IL-18 have been reported to affect the outcome of natural and pegylated interferon and ribavirin-treated HCV infection. Methods To clarify their associatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9841f77409e6691443e5992720ab9594
https://doi.org/10.3851/imp1869
https://doi.org/10.3851/imp1869
Autor:
Susumu Morita, Kaname Yoshizawa, Akihiro Matsumoto, Atsushi Kamijo, Yuki Ichikawa-Yamada, Takeji Umemura, Yoshinori Tsukahara, Takefumi Kimura, Satoru Joshita, Tetsuya Ichijo, Eiji Tanaka
Publikováno v:
Hepatology Research. 41:904-909
A 58-year-old woman with chronic hepatitis C developed interstitial pneumonia (IP) while undergoing pegylated interferon (PEG IFN)-α-2a and ribavirin (RBV) therapy. Serum levels of sialylated carbohydrate antigen KL-6 (KL-6), a known marker of disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fd5e4aa68b623b50d036307bd8f0247
https://doi.org/10.1111/j.1872-034x.2011.00837.x
https://doi.org/10.1111/j.1872-034x.2011.00837.x
Autor:
Yoshihiko Katsuyama, Masao Ota, Satoru Joshita, Eiji Tanaka, Kaname Yoshizawa, Takeji Umemura, Suguru Yoneda, Akihiro Matsumoto, Tetsuya Ichijo
Publikováno v:
Hepatology Research. 41:587-593
Aim: Serum chemokine levels and amino acid substitutions in the interferon-sensitivity determining region (ISDR) and core region have been associated with treatment outcome of pegylated interferon and ribavirin therapy in genotype 1 hepatitis C virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66ed8f53b0f3a34247530e9895980d60
https://doi.org/10.1111/j.1872-034x.2011.00802.x
https://doi.org/10.1111/j.1872-034x.2011.00802.x